Search
for
Sort by
Research 331–360 of 1000+
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Nutritional management in women with polycystic ovary syndrome: A review study
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Polycystic Ovary Syndrome
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Idiopathic Hirsutism*
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Mood disorders and quality of life in polycystic ovary syndrome
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Androgens in women
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Acne in women
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Hormone therapy in acne
- Alterations in androgen conjugate levels in women and men with alopecia
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- Female Adolescent Hair Disorders